These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 9521200
1. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy. Mourad G, Vela C, Ribstein J, Mimran A. Transplantation; 1998 Mar 15; 65(5):661-7. PubMed ID: 9521200 [Abstract] [Full Text] [Related]
2. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G. Kidney Int; 1999 Feb 15; 55(2):674-85. PubMed ID: 9987092 [Abstract] [Full Text] [Related]
4. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings. Gotti E, Perico N, Perna A, Gaspari F, Cattaneo D, Caruso R, Ferrari S, Stucchi N, Marchetti G, Abbate M, Remuzzi G. J Am Soc Nephrol; 2003 Mar 15; 14(3):755-66. PubMed ID: 12595513 [Abstract] [Full Text] [Related]
9. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group. Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789 [Abstract] [Full Text] [Related]
16. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy. Gonzalez Molina M, Seron D, Garcia del Moral R, Carrera M, Sola E, Jesus Alferez M, Gomez Ullate P, Capdevila L, Gentil MA. Transplantation; 2004 Jan 27; 77(2):215-20. PubMed ID: 14742984 [Abstract] [Full Text] [Related]
17. Acute effects of nifedipine in renal transplant recipients treated with cyclosporine or azathioprine. Hilbrands LB, Hoitsma AJ, van Hamersvelt HW, Wetzels JF, Huysmans FT, Koene RA. Am J Kidney Dis; 1994 Nov 27; 24(5):838-45. PubMed ID: 7977327 [Abstract] [Full Text] [Related]
18. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine. Aleksic I, Baryalei M, Busch T, Pieske B, Schorn B, Strauch J, Sîrbu H, Dalichau H. Transplantation; 2000 Apr 27; 69(8):1586-90. PubMed ID: 10836367 [Abstract] [Full Text] [Related]
19. A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients. Chan C, Maurer J, Cardella C, Cattran D, Pei Y. Transplantation; 1997 May 27; 63(10):1435-40. PubMed ID: 9175807 [Abstract] [Full Text] [Related]
20. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function. Weir MR, Blahut S, Drachenburg C, Young C, Papademitriou J, Klassen DK, Cangro CB, Bartlett ST, Fink JC. Am J Nephrol; 2004 May 27; 24(4):379-86. PubMed ID: 15237243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]